Dexamethasone suppression tests in liver cirrhosis - abnormalities in patients with primary hepatocellular carcinoma.

Akanji, A.O., Ola, S.O., Malabu, U.H., Oduwole, O.O., and Olubuyide, I.O. (1995) Dexamethasone suppression tests in liver cirrhosis - abnormalities in patients with primary hepatocellular carcinoma. Medical Science Research, 23. pp. 781-782.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

 
2


Abstract

[Extract] Primary hepatocellular carcinoma (PHC), an important cause of morbidity and mortality in many African and Asian countries [1-4], has protean manifestations. Aside from its classical clinical and biochemical presentation, PHC is associated with a variety of paraneoplastic phenomena, including increased erythropoietin production, hypoglycaemia, hypercholesterolaemia and hypercalcaemia [5,6]. The terminal patient with PHC in Nigeria may have a variety of fluid and electrolyte abnormalities, particularly resistant ascites and hypokalaemia.

Item ID: 23507
Item Type: Article (Research - C1)
ISSN: 0269-8951
Keywords: cortisol, dexamethasone supression tests, liver diseases, hepatoma, hepatocellular carcinoma
Date Deposited: 03 Jan 2013 23:00
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110306 Endocrinology @ 100%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920106 Endocrine Organs and Diseases (excl. Diabetes) @ 100%
Downloads: Total: 2
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page